Care Bare Rx Review 2026: A $199 Headline and a Price List That Is Not There

MyGLP1Reviews is an independent review site. We are not a medical provider and we are not affiliated with Care Bare Rx, CareValidate, Inc. or CareGLP. See our review method and affiliate disclosure. Care Bare Rx pays us. Links to Care Bare Rx on this page are affiliate links and we earn a commission if you start a plan, at no extra cost to you and regardless of which plan you choose. It changed nothing about what is written below. This review was built from the company’s own published pages, and where those pages contradict each other we say so.
The short version

Care Bare Rx is the most distinctive brand in this comparison and the least specific about money. The home page advertises weight-loss treatment starting at $199. The weight-loss product page itself contains no prices at all, and the FAQ refers to listed prices that are not listed anywhere on the site. The terms of use are a template belonging to a different platform, CareGLP, dated 1 January 2024, which says consultation fees are non-refundable, all sales are final, and that the final charge to your card may vary. What Care Bare Rx does do well is disclose compounding clearly and name its pharmacies and clinicians. What it does not do is tell you what anything costs before you start an intake.

Check current Care Bare Rx pricing Compare all twelve providers

The Care Bare Rx link above is an affiliate link. The comparison link is not.

What it costs

What you are buying Advertised price What the page actually says
Weight loss, home page Starting at $199 per month The only weight-loss price published anywhere on the site
Weight loss product page No price shown We searched the page. There is no dollar figure on it
Hair growth / ED / NAD+ From $99, $99 and $199 Published on the home page as starting prices
Billing period Not stated The terms contain no mention of subscriptions, renewals or billing intervals
Consultation fee Not published Non-refundable under the terms. The amount is not disclosed in advance
Final amount charged May vary The terms warn the charge may fluctuate depending on medication prescribed and pharmacy used

The FAQ makes this worse rather than better. Asked what the programme costs, it says price varies by dose and medication but that the listed prices include the telehealth consultation, the treatment plan, a monthly prescription, shipping and support. That is a reasonable, all-in bundle. There is simply no list. The single $199 figure on the home page is the whole disclosure, and the page that should carry the price list carries none.

Note also the phrase a monthly prescription in that answer, which is the only hint anywhere that this is a recurring arrangement. The terms never use the words subscription, renewal or recurring. So a buyer cannot establish, from published information, either the price or how often it will be charged.

A correction to our own comparison table

Our main comparison described Care Bare Rx as oral GLP-1s only. Reading the weight-loss page in full for this review, that is not right, and we have corrected it here. The page offers oral semaglutide sold under the Rybelsus brand name and an oral tirzepatide form, and it also offers injectable compounded semaglutide and injectable compounded tirzepatide, described as once-weekly. We publish corrections rather than quietly editing, so this is the record.

One phrase on the weight-loss page deserves attention. Describing oral tirzepatide, the page says the FDA-approved version is injectable and that oral options may be available through compounded or research-based prescribing, depending on provider discretion. Research-based is not a recognised category of prescribing. If you are considering the oral tirzepatide specifically, ask which licensed compounding pharmacy prepares it and on what basis, before you pay a consultation fee that the terms say you will not get back.

The terms are a borrowed template, and not the only place they appear

Care Bare Rx publishes one commercial document. It is dated 1 January 2024 and opens with a block-capital notice about CareGLP being intended for non-emergency conditions. The named entity is CareValidate, Inc., with Care Bare Rx described as a Delaware corporation at 4575 Webb Bridge Road, Alpharetta, Georgia. A customer testimonial on the home page also refers to CareGLP rather than to Care Bare Rx, which suggests the review was collected on the underlying platform rather than for this brand.

The refund position in that document is the standard hard line: consultation fees are not eligible for refund, prescription products cannot be returned for reuse or resale, and all sales are final. No notice period is published because no renewal is acknowledged. And the same clause we found on Synergy Rx appears here word for word: the final charge to your card may fluctuate depending on the medication prescribed and the pharmacy chosen, with support contacting you if it does.

Care Bare Rx and Synergy Rx are the same operation behind two brands. This is verifiable from their own published pages. Both publish the identical CareGLP terms document dated 1 January 2024, including the same variable-charge clause. Both name the same medical group, Lion MD, led by Dr Ana Lisa Carr MD and Dr Kelly Tenbrink MD, with the same NPI numbers. Both list the same four compounding pharmacies: Belmar, Strive, Epiq Scripts and Casa Pharma Rx. They are sold as two independent choices in this market. They are not two independent choices.

Where the disclosure is genuinely good

Three things here are better than the category average, and they should be said. The weight-loss page carries the compounding disclaimer in plain language, stating that physicians may prescribe compounded medications to meet patient requirements or drug shortages and that compounded medication is not evaluated by the FDA for safety or effectiveness. The FAQ names the medical group and four supporting physicians with NPI numbers, and names all four pharmacy partners with addresses and phone numbers. And the FAQ states plainly that CareValidate does not itself provide medical or pharmacy services and that payment does not guarantee a prescription will be written or dispensed, which is a more candid statement of that risk than most competitors make.

Set against that is a marketing habit worth flagging. The weight-loss page cites clinical studies of FDA-approved medications such as Ozempic, and a figure of six times more weight lost than with diet and exercise alone, on a page selling compounded product. The trial evidence belongs to the approved brand. Borrowing it to sell a compounded preparation is common in this category and it is still misleading. Our guide to compounded versus FDA-approved GLP-1s explains why the two are not interchangeable.

The brand also references Ozempic and Wegovy by name in a home page bullet about the GLP-1 medications it offers, which reads as though brand product is on the menu. The weight-loss page describes semaglutide and tirzepatide as compounded, apart from oral Rybelsus. Anyone buying on the strength of a brand name should confirm exactly which product is being dispensed.

Who runs it, and what it covers

Telehealth services are provided by CareValidate at the Alpharetta address, with a published phone number, on a platform described as Care360 and stated to be SOC 2 and HIPAA compliant. Service is offered in all 50 states and Puerto Rico. FSA and HSA cards are accepted. Providers review intake forms within 24 hours. Spanish-speaking clinicians are advertised. Alongside the terms, the site publishes a privacy policy, a notice of privacy practices, a medical consent and a California residents notice, which is a more complete legal set than Synergy Rx offers on the same platform.

The brand is explicitly built for LGBTQ+ customers while stating it is not only for them. That is a positioning choice rather than a clinical one, and it has no bearing on price or refund terms, but it is the reason a reader may have arrived here.

Who this suits, and who it does not

Who Care Bare Rx is a reasonable fit for

  • Buyers who want the compounding disclaimer stated on the product page rather than buried, and who want the treating clinicians and pharmacies named before they sign up.
  • People who want oral GLP-1 options, including branded Rybelsus, alongside injectables.
  • Anyone who values a full legal set: privacy policy, privacy practices notice, medical consent and a California notice are all published.
  • Customers who want a provider that has deliberately built its service around LGBTQ+ patients.

Who should look elsewhere

  • You want to know the price before starting an intake. There is one figure on the whole site and the weight-loss page has none.
  • You want to know how often you will be charged. No billing interval is published anywhere.
  • You want the amount you agree to be the amount taken. The terms explicitly allow the final charge to vary.
  • You want a refund window. Consultation fees are non-refundable and all sales are final, with no notice period published. See our Trimi Health review for the clearest alternative.
  • You are weighing this against Synergy Rx as an independent second option. It is the same platform, terms, medical group and pharmacies.
  • You want oral tirzepatide on a clearly described legal basis. The page’s reference to research-based prescribing needs an explanation before you pay.

See Care Bare Rx current treatments

Affiliate link. Verify every figure on the provider’s own site before you pay. Pricing and policy pages in this category change without notice.

Compare this against the rest of the market

One provider in isolation tells you very little. These pages run a single variable across all twelve companies we track.

How we sourced this

The $199 weight-loss figure and the hair, ED and NAD+ starting prices were read from the Care Bare Rx home page. The absence of any price on the weight-loss product page was established by reading that page in full. The product range, the Rybelsus and oral tirzepatide descriptions, the research-based prescribing phrase, the compounding disclaimer and the borrowed clinical-trial claim were read from the same weight-loss page. The operating entity, the Alpharetta address, the CareGLP naming, the 1 January 2024 date, the non-refundable consultation fee, the all-sales-final position and the variable-charge clause were read from the published terms and conditions. The platform description, the medical group and physician NPI numbers, the four pharmacy partners, the states served and the payment-does-not-guarantee-a-prescription statement were read from the FAQ. The shared-platform finding was established by comparing these documents directly against the equivalent pages on Synergy Rx. Everything was read on the date at the top of this page. We have not been through checkout and we have not tested cancellation. Terms change without notice, so verify before you buy.

Medical note

This is consumer purchasing information, not medical advice. Speak with a licensed clinician who knows your history before starting, stopping or switching a prescription. See our medical disclaimer.